Company / Corporate
Immedica Pharma AB.
Follow Immedica Pharma ABImmedica is a pharmaceutical company focused on the commercialization of medicines for rare diseases and specialty care products.[1]
02Deals
Deals on Carrywatch
Every deal that names Immedica Pharma AB, and its role in each.
Immedica Pharma AB / Marinus Pharmaceuticals, Inc.
Immedica completes acquisition of Marinus Pharmaceuticals, Inc.
See deal detailsImmedica Pharma AB / Aeglea BioTherapeutics, Inc.
Immedica Pharma AB completes pegzilarginase asset purchase from Aeglea BioTherapeutics, Inc.
See deal detailsDeal Web
Immedica Pharma AB and 1 firm it shares a posted deal with, and the path to any other firm.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01Immedica completes acquisition of Marinus Pharmaceuticals, Inc.
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming Immedica Pharma AB:
- P01
- P02